PDA

View Full Version : Methadone Treatment of Chronic Pain after Spinal Cord Injury (SCI) or Amputation


Wise Young
08-06-2001, 12:01 AM
http://clinicaltrials.gov/ct/gui/c/a1b/show/NCT00006448?order=5&JServSessionId zone_ct=zhn5b9gan1 (http://clinicaltrials.gov/ct/gui/c/a1b/show/NCT00006448?order=5&JServSessionIdzone_ct=zhn5b9gan1)

Treatment of Chronic Pain after Spinal Cord Injury (SCI) or Amputation

This study is currently recruiting patients.

Sponsored by

National Institute of Child Health and Human Development (NICHD)

Purpose

Pain is a major problem for people after spinal cord injuries and amputations. This is a study to test how pain is affected by adding methadone to a six-week program of weekly physical therapy, relaxation training and counseling. Individuals who qualify for this study will receive a comprehensive medical and physical therapy evaluation.

Condition Treatment or Intervention
Spinal Cord Injuries
Amputation, Traumatic
Pain

Behavior:cognitive therapy
Procedure:Physical Therapy
Drug:Methadone


MEDLINEplusrelated topics:Pain; SpinalCordInjuries

Study Type:Interventional
Study Design:Treatment,Randomized,Double-Blind Method,Placebo Control,Efficacy Study,Single Group Assignment

Official Title:Spinal Cord Injury (SCI) and Amputation Pain Prevention and Treatment

Further Study Details:

Pain has a major impact on the functioning of individuals with spinal cord injuries and individuals with amputations. This double-masked randomized trial to evaluate the utility of a combination of psychological intervention and physical therapy in order to improve pain reduction, increase physical functioning and quality of life for patients with pain associated with spinal cord injuries or amputations will compare the effect of a 6 week program of physical therapy and cognitive-behavioral therapy with methadone to one without methadone (n = 400). Secondary outcomes are to evaluate the maintenance of effects of the combined intervention and to evaluate the usefulness of a course of opioid therapy compared to active placebo medication. Based on the sample size, all measures have greater than 0.7 power to detect major within group differences at posttreatment, 6-month follow-up, and 12-month follow-up (taking into account a 15% attrition rate, alpha .05). Patients who qualify for this study will receive a comprehensive medical and physical therapy evaluation at baseline. Outcome will be assessed by the physician, psychiatrist and physical therapist who are all masked both to the treatment condition and therapy. Pain is assessed through self-report (measures include pain inventories) and clinical interview.

Eligibility

Ages Eligible for Study: 18 Years - 75 Years, Genders Eligible for Study: Both

Participants: Patients

Criteria


Inclusion Criteria:
* Individuals with spinal cord injury or amputation, who have persistent pain of three months or longer duration.


Exclusion Criteria:
* Pregnant women
* Allergy to latex, methadone, or diphenydramine * Surgery planned * History of substance abuse in past two years * History of major psychiatric disorder

Expected Total Enrollment: 400

Location and Contact Information

Jill Smith 1-412-578-3115 smithjc@anes.upmc.edu

Pennsylvania
University of Pittsburg Medical Center,Pittsburgh, Pennsylvania, 15213, United States;Recruiting

Thomas E. Rudy, Ph.D. 412-578-3115 rudyte@anes.upmn.edu

Study chairs or principal investigators

Thomas E. Rudy, Ph.D., Principal Investigator University of Pittsburgh Medical Center


More Information

Click here for more information about the National Institute of Child Health and Human Development (NICHD).

Study ID Numbers NICHD-0108; 5P01 HD33989-05 NLM Identifier NCT00006448

Date study startedAugust 1996; Date Study Completed July 2001 Record last reviewed March 2000

[This message was edited by Wise Young on August 06, 2001 at 12:41 PM.]

Wise Young
04-06-2002, 09:31 AM
Updated link to clinicaltrials.gov for this trial

http://clinicaltrials.gov/ct/gui/c/w1r/show/NCT00006448?order=1&JServSessionIdzone_ct=bhno4suvt1

Wise Young
04-06-2002, 11:09 AM
http://clinicaltrials.gov/ct/gui/c/a1r/show/NCT00006448?order=6&JServSessionIdzone_ct=nh9kvtwwa1